ThibaultPAttiaJOldmeadowC.A prolonged antibiotic protocol to treat persistent Chlamydophila pneumoniae infection improves the extracranial venous circulation in multiple sclerosis.Phlebology2018;
33: 397–406.
2.
ZwischenbergerBABeasleyMMDavenportDLet al.
Meta-analysis of the correlation between chronic cerebrospinal venous insufficiency and multiple sclerosis.Vasc Endovascular Surg2013;
47: 620–624.
3.
KuglerNPatelPJLeeCJ.Chronic cerebrospinal venous insufficiency in multiple sclerosis: a failed concept.Vasc Specialist Int2015;
31: 11–14.
4.
CardaioliGDi FilippoMBianchiAet al.
Extracranial venous drainage pattern in multiple sclerosis and healthy controls: application of the 2011 diagnostic criteria for chronic cerebrospinal venous insufficiency.Eur Neurol2016;
76: 62–68.
5.
SchraubenEMKohnSMacdonaldJet al.
Four-dimensional flow magnetic resonance imaging and ultrasound assessment of cerebrospinal venous flow in multiple sclerosis patients and controls.J Cereb Blood Flow Metab2017;
37: 1483–1493.
6.
TsivgoulisGFaissnerSVoumvourakisKet al. ‘
Liberation treatment’ for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free.Brain Behav2015;
5: 3–12.
7.
McKayKAKwanVDugganTet al.
Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review.Biomed Res Int2015;
2015: 817238.
8.
LibbeyJECusickMFFujinamiRS.Role of pathogens in multiple sclerosis.Int Rev Immunol2014;
33: 266–283.
9.
IvanovaMVKolkovaNIMorgunovaEYet al.
Role of chlamydia in multiple sclerosis.Bull Exp Biol Med2015;
159: 646–648.
10.
WoessnerRGrauerMTFreseAet al.
Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis. Infection2006;
34: 342–344.
